Concepedia

Publication | Open Access

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

DOIFull Paper Access

142

Citations

18

References

2014

Year

Matthias Holdhoff, Prakash Ambady, Ahmed Abdelaziz, Guneet Sarai, David Bonekamp, Jaishri O. Blakeley, Stuart A. Grossman, Xiaobu Ye
Neurology

Abstract

This study provides Class III evidence that in immunocompetent patients with PCNSL, HD-MTX plus rituximab compared with HD-MTX alone improves CR and overall survival rates.

References

YearCitations

Page 1